Written question asked by Baroness Ritchie of Downpatrick (Labour) on Tuesday, 3 September 2024, in the House of Lords. It was due for an answer on Tuesday, 17 September 2024. It was answered by Baroness Merron (Labour) on Thursday, 19 September 2024 on behalf of the Department of Health and Social Care.
Breast Cancer: Statistics
- Question
-
To ask His Majesty's Government what assessment they have made of the quality and consistency of triple negative breast cancer data collected in England; and what steps they are taking to improve it.
- Answer
-
Data on triple negative breast cancer for England is collected through the National Disease Registration Service (NDRS). An NDRS Quality Assurance Team is in place to identify, investigate, and monitor data quality issues, with over 130 Quality Assurance reports being run each month as well as quarterly reports to assess the completeness of key data.
To drive up the completeness of the data for triple negative breast cancer, progesterone receptor status, human epidermal growth factor receptor in situ hybridization status, and oestrogen receptor status are part of the Cancer Outcomes and Services Data set, which supports national registration.
Secondary information
- Type
- Written question
- Reference
- HL727
- Session
- 2024-26
- Related items
- Subjects
- Breast cancer Standards Statistics
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2025-09-05 20:30:21 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2024-25/HL727
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2024-25/HL727
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2024-25/HL727